Professor
University of New South Wales, Australia
Prof Thomas is the Director of the UNSW Centre for Molecular Oncology, and Head of the Genomic Cancer Medicine Laboratory at the Garvan Institute of Medical Research. As a clinician-scientist, his focus is on the application of genomic technologies to the understanding and management of cancer. Prof Thomas founded the Australasian Sarcoma Study Group, a national clinical research organisation, and established Australia’s leading adolescent and young adult cancer unit at the Peter MacCallum Cancer Centre. Dr Thomas leads the International Sarcoma Kindred Study, now recruiting from 23 centres in 7 countries, and led the first international study of denosumab in Giant Cell Tumor of bone, leading to FDA and TGA approval. He has over 200 research publications, including lead or senior author papers in Science, Cancer Cell, Molecular Cell, Journal of Clinical Investigation, Lancet Oncology, JAMA Oncology, and Journal of Clinical Oncology. Over the past 5 years, he has established the Australian Genomic Cancer Medicine Centre, a national precision medicine program for patients with rare and early onset cancers. In 2018, he was President of the Connective Tissue Oncology Society, the peak international body in his field.
